1. Home
  2. About
  3. Advisory Council on Blood Stem Cell Transplantation
  4. September 25, 2020

September 25, 2020

Agenda
Meeting Agenda (PDF - 107.82 KB)
Presentations
Health Resources and Services Administration, Division of Transplantation – Overview (PDF - 603.37 KB)
Blood Stem Cell Transplantation Trends: An Overview (PDF - 877.28 KB)
Haploidentical Transplantation: An Overview (PDF - 791.21 KB)
Mismatched Unrelated Donor Transplantation: An Overview (PDF - 1.16 MB)
A Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning and Transplantation of Double Unrelated Umbilical (PDF - 596.74 KB)
CAR- T Cell Immunotherapies (PDF - 2.86 MB)
Cord Blood in Regenerative Medicine (PDF - 4.87 MB)
Cord Blood Transplantation: Challenges and Opportunities (PDF - 2.61 MB)
Cord Blood Derived CAR NK Cells (PDF - 1.91 MB)
CCR5 Genotype (PDF - 945.07 KB)
COVID-19: Impact on Blood Stem Cell Transplantation (PDF - 1.11 MB)
Meeting Summary
Meeting Summary Notes (PDF - 291.96 KB)

Recommendations

Recommendation 33

HRSA should continue to support collection of high-quality cord blood units through the NCBI to support the development of a demonstration project to optimize the utilization of cord blood for transplantation by providing guidance to transplant centers on uses of cord blood and coordinate and share best practices among entities involved in cord blood collection, selection, logistics, and transplant.  

Accessibility Disclaimer
Persons using assistive technology may not be able to fully access information in these files. For assistance, contact comments@hrsa.gov or 888-275-4772 (TTY: 877-489-4772).